The bacteria present in the intestine provide information about the quantities of fungi of the potentially disease-causing Candida genus. Among them, and surprisingly, are lactic acid bacteria that are known for their protective effect against fungal infections. The findings of researchers add another piece to the puzzle of understanding the human gut microbiome.
The human gut microbiome is an extremely complex community in which different microorganisms keep each other in check. However, if an imbalance occurs due to antibiotics or other environmental influences, individual species can spread and lead to infection. Fungi of the Candida genus, for example, are present in the intestines of many healthy people. They are usually harmless, but can also cause dangerous systemic infections.
Studying these interactions in the intestine is difficult. The several hundred species of bacteria and fungi can only be partially cultivated in the laboratory, and many are not even known. Researchers are therefore trying to shed more light on the intestine using metagenome studies.
For the study now published in Nature Communications, the researchers examined stool samples from 75 cancer patients and found that certain bacterial species always appear in greater numbers when the amount of fungi from the Candida genus is also high. "With these data, we developed a computer model that was able to predict the amount of Candida in another group of patients with an accuracy of about 80 percent based on bacterial species and amounts alone," explains the lead author of the study. These bacteria included mainly oxygen-tolerant species.
What surprised the researchers was not only how successful the prediction of the amount of fungi based on the bacterial species present was, but also which bacteria correlated with high amounts of fungi. "We found an increased number of bacterial species that produce lactic acid, including Lactobacillus species," the author explains. It's a finding that was not expected. "I could hardly believe it at first, so I checked several times, always with the same result."
The researchers' hunch: Lactic acid bacteria, particularly of the genus Lactobacillus, favor Candida proliferation but at the same time make the fungus less virulent. This could be due to the fact that Candida species can switch their metabolism to be able to use the lactate produced by lactic acid bacteria. This gives them a competitive advantage over other fungi such as Saccharomyces cerevisiae, as the researchers discovered in additional experiments. However, the metabolic switch also apparently causes Candida to remain in its usually harmless spherical yeast form instead of forming fungal hyphae that could invade the intestinal mucosa.
"There is also a suggestion that certain groups of Lactobacillus species might have different effects," the author says. To investigate this, the next step will be to perform more detailed genomic analyses of the bacteria.
"For the current study, we examined stool samples from cancer patients who are particularly at risk for fungal infections," the author explains. For further studies, samples from healthy subjects could be included to develop long-term strategies for at-risk patients based on their microbiome.
https://www.nature.com/articles/s41467-023-38058-8
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fcandida-expansion-in&filter=22
Intestinal bacteria influence the growth of fungi
- 1,046 views
- Added
Edited
Latest News
AI based histologic biomark…
By newseditor
Posted 30 Nov
Repairing nerve cells after…
By newseditor
Posted 30 Nov
A gene regulating fat stora…
By newseditor
Posted 30 Nov
Leveraging CRISPR to target…
By newseditor
Posted 30 Nov
Multi-chamber heart organoi…
By newseditor
Posted 29 Nov
Other Top Stories
Tumors hijack the cell death pathway to escape radiation induced im…
Read more
Heart cell proliferation by an oncogene, Myc
Read more
How 'hypermutated' malignant brain tumors escape chemotherapy and i…
Read more
Single cell division error may be responsible for complexity in can…
Read more
Stabilizing protein phosphatases to target cancer
Read more
Protocols
Personalized drug screening…
By newseditor
Posted 30 Nov
Multi-chamber cardioids unr…
By newseditor
Posted 29 Nov
Microfluidic-based skin-on-…
By newseditor
Posted 28 Nov
Biology-guided deep learnin…
By newseditor
Posted 26 Nov
Accurate prediction of prot…
By newseditor
Posted 25 Nov
Publications
Pleiotrophin ameliorates ag…
By newseditor
Posted 30 Nov
Mitf is a Schwann cell sens…
By newseditor
Posted 30 Nov
OsHLP1 is an endoplasmic-re…
By newseditor
Posted 30 Nov
Probiotic treatment with Bi…
By newseditor
Posted 30 Nov
Metabolic immunity against…
By newseditor
Posted 30 Nov
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar